|
- Venetoclax - Wikipedia
Venetoclax, sold under the brand names Venclexta and Venclyxto, is a medication used to treat adults with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), or acute myeloid leukemia (AML) [7] [8]The most common side effects are low levels of neutrophils (a type of white blood cell), diarrhea, nausea, anemia (low red blood cell counts), nose and throat infection and tiredness
- Venetoclax: Uses, Dosage, Side Effects, Warnings - Drugs. com
Venetoclax (brand name Venclexta) may be used to treat CLL, SLL, or AML in those aged 75 years or older or with other conditions that prevent intensive chemotherapy Venetoclax is used in combination with azacitidine, decitabine, or low-dose cytarabine
- VENCLEXTA® (venetoclax tablets): CLL SLL and AML Treatment
Discover VENCLEXTA® (venetoclax tablets): An oral therapy to help you fight certain blood cancers See full Prescribing and Safety information
- Venetoclax - NCI - National Cancer Institute
Venetoclax is also being studied in the treatment of other types of cancer More About Venetoclax Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug MedlinePlus Information on Venetoclax - A lay language summary of important information about this drug that may include the following:
- Venetoclax (oral route) - Mayo Clinic
Venetoclax is also used together with other medicines (eg, azacitidine, decitabine, low-dose cytarabine) to treat newly-diagnosed acute myeloid leukemia (AML) in adults 75 years of age and older or who have other medical conditions that prevent the use of standard chemotherapy Venetoclax is an antineoplastic agent (cancer medicine)
- venetoclax (Rx) - Medscape Drugs Diseases
Venetoclax helps restore the process of apoptosis by binding directly to the Bcl-2 protein, displacing proapoptotic proteins like BIM (a novel member of the Bcl-2 family), triggering mitochondrial outer membrane permeabilization, and activating caspases Absorption Peak plasma time: 5-8 hr
- Venclexta (venetoclax) - Uses, Side Effects, and More
Venclexta (venetoclax) is commonly used for the following conditions Chronic lymphocytic leukemia (CLL) Small lymphocytic lymphoma (SLL) Acute myeloid leukemia (AML)
- Venetoclax (Venclexta) Tablets - FDA
Venetoclax received Orphan drug status for the treatment of CLL and was granted Breakthrough Therapy Designation for the 17p deletion CLL development program The application was granted Priority
|
|
|